Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Correlation of the in vivo anticoagulant, antithrombotic, and antimetastatic efficacy of warfarin in the rat.

Smith GF, Neubauer BL, Sundboom JL, Best KL, Goode RL, Tanzer LR, Merriman RL, Frank JD, Herrmann RG.

Thromb Res. 1988 Apr 1;50(1):163-74.

PMID:
3400078
2.

Comparison of the anticoagulant and antithrombotic effects of YM-75466, a novel orally-active factor Xa inhibitor, and warfarin in mice.

Sato K, Taniuchi Y, Kawasaki T, Hirayama F, Koshio H, Matsumoto Y, Iizumi Y.

Jpn J Pharmacol. 1998 Oct;78(2):191-7.

3.

Vitamin K-dependent procoagulant in cancer cells: a potential target for the antimetastatic effect of warfarin?

Donati MB, Roncaglioni MC, Falanga A, Casali B, Semeraro N.

Haemostasis. 1986;16(3-4):288-94.

PMID:
3530903
4.
5.

A comparison of the beta-D-xyloside, odiparcil, to warfarin in a rat model of venous thrombosis.

Toomey JR, Abboud MA, Valocik RE, Koster PF, Burns-Kurtis CL, Pillarisetti K, Danoff TM, Erhardt JA.

J Thromb Haemost. 2006 Sep;4(9):1989-96.

6.

Antithrombotic effects and bleeding time of thrombin inhibitors and warfarin in the rat.

Elg M, Gustafsson D, Carlsson S.

Thromb Res. 1999 May 1;94(3):187-97.

PMID:
10326765
8.
9.
11.

Experimental arterial thrombosis in genetically or diet induced hyperlipidemia in rats--role of vitamin K-dependent clotting factors and prevention by low-intensity oral anticoagulation.

De Curtis A, D'Adamo MC, Amore C, Polishchuck R, Castelnuovo AD, Donati MB, Iacoviello L.

Thromb Haemost. 2001 Dec;86(6):1440-8.

PMID:
11776312
12.

Antitumor and antimetastatic effect of warfarin and heparins.

Bobek V, Kovarík J.

Biomed Pharmacother. 2004 May;58(4):213-9. Review.

PMID:
15183845
13.

Warfarin inhibits both procoagulant activity and metastatic capacity of Lewis lung carcinoma cells. Role of vitamin K deficiency.

Colucci M, Delaini F, de Bellis Vitti G, Locati D, Poggi A, Semeraro N, Donati MB.

Biochem Pharmacol. 1983 Jun 1;32(11):1689-91.

PMID:
6870908
15.

Inhibitory effect of warfarin on the metastasis of the PAIII prostatic adenocarcinoma in the rat.

Neubauer BL, Bemis KG, Best KL, Goode RL, Hoover DM, Smith GF, Tanzer LR, Merriman RL.

J Urol. 1986 Jan;135(1):163-6.

PMID:
3941458
16.

Moderate anticoagulation by salicylate prevents thrombosis without bleeding complications. An experimental study in rats.

Roncaglioni MC, Reyers I, Cerletti C, Donati MB, de Gaetano G.

Biochem Pharmacol. 1988 Dec 15;37(24):4743-5.

PMID:
3202906
17.

Cancer cell procoagulants and their pharmacological modulation.

Donati MB, Semeraro N.

Haemostasis. 1984;14(5):422-9. Review.

PMID:
6398243
18.

T-686, a novel inhibitor of plasminogen activator inhibitor-1, inhibits thrombosis without impairment of hemostasis in rats.

Ohtani A, Murakami J, Hirano-Wakimoto A.

Eur J Pharmacol. 1997 Jul 9;330(2-3):151-6.

PMID:
9253948
19.

The impact of vitamin K-dependent factor depletion by warfarin on platelet-rich thrombosis after deep arterial injury.

McBane RD 2nd, Hassinger NL, Grill DE, Chesebro JH.

J Thromb Haemost. 2004 Oct;2(10):1834-41.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk